Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Edwards to market PLC's TMR heart laser in US:

This article was originally published in Clinica

Executive Summary

Edwards Lifesciences is to have exclusive rights to sell PLC Medical Systems' next generation CO2 TMR heart laser in the US under a multi-year agreement. The product is awaiting FDA approval. Edwards will also take a $4 million equity investment in Franklin, Massachusetts-based PLC and will receive warrants to buy three million shares. "We believe Edwards' substantial sales and marketing resources combined with PLC's technological leadership will establish CO2 TMR as the standard of care in laser-powered heart revascularisation," said Mark Tauscher, PLC's CEO.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069556

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel